Abstract | BACKGROUND: METHODS: Mice model of MIRI was established and randomly divided into three groups: control group, ischemia reperfusion group, and remote ischemic postconditioning group. Infarction size was detected by Evans blue and TTC staining. Cardiac function was detected by echocardiography measurement. The protein levels of RAGE, HMGB1, P-AKT, and ERK1/2 were detected by Western blot 120 min following reperfusion. RESULTS: RIPostC could decrease the infarct size and increase LVEF and FS compared with I/R group. Two hours after myocardial ischemia reperfusion, the levels of RAGE and HMGB1 were significantly decreased in RIPostC group compared with those in I/R group. The level of p-AKT was significantly higher in the RIPostC group than in the I/R group. LY294002 significantly attenuated RIPostC-increased levels of Akt phosphorylation. CONCLUSION: RIPostC may inhibit the expression of RAGE and HMGB1 and activate PI3K/Akt signaling pathway to extenuate ischemic reperfusion injury in mice. It could further suppress the oxidative stress, have antiapoptosis effect, and reduce inflammatory reaction, but this effect has certain timeliness.
|
Authors | Xiangming Wang, Junhong Wang, Tiantian Tu, Zakaria Iyan, Deeraj Mungun, Zhijian Yang, Yan Guo |
Journal | BioMed research international
(Biomed Res Int)
Vol. 2018
Pg. 4565630
( 2018)
ISSN: 2314-6141 [Electronic] United States |
PMID | 29789792
(Publication Type: Journal Article)
|
Chemical References |
- Ager protein, mouse
- HMGB1 Protein
- HMGB1 protein, mouse
- Receptor for Advanced Glycation End Products
|
Topics |
- Animals
- Disease Models, Animal
- HMGB1 Protein
(metabolism)
- Ischemic Postconditioning
(methods)
- Male
- Mice
- Mice, Inbred C57BL
- Myocardial Reperfusion Injury
(prevention & control)
- Receptor for Advanced Glycation End Products
(metabolism)
- Signal Transduction
(physiology)
|